Genome editing is a revolutionary new technology that enables scientists to make precise changes to an organism's genetic code. It is a powerful tool used to study gene function, create disease models, and develop new therapies. With genome editing, scientists can make specific changes to DNA, RNA, and proteins, allowing them to alter an organism's characteristics, such as its color or size. Genome editing works by altering the sequence of an organism's genetic material. This can be done using a variety of approaches, such as CRISPR-Cas9, Zinc Finger Nucleases, and TALENs. Each approach has its own advantages and drawbacks, but all work by recognizing specific sequences of DNA and using enzymes to cut and modify that sequence. The potential applications of genome editing are vast, from creating transgenic animals for biomedical research to engineering plants for better yields. It can also be used to correct genetic defects in humans, such as genetic diseases like cystic fibrosis or sickle cell anemia. Genome editing is a rapidly evolving field with great potential, but it also raises ethical questions. It is important to consider the implications of such powerful technology and ensure that it is used responsibly.
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States